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Effect of Alcohol Consumption on the Risk of 
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Alcohol consumption is a common behavior in social circumstances worldwide. 
Epidemiological studies have suggested that moderate alcohol consumption reduces 
cardiovascular morbidity and mortality. The cardiovascular protective effects of alcohol 
may be attributed to its antioxidant, vasorelaxant, and antithrombotic properties, 
elevation of high-density lipoprotein or increase of nitric oxide production. Erectile 
dysfunction (ED) is a harbinger of cardiovascular diseases. Most epidemiological 
studies have also found that alcohol consumption, like its relationship with coronary 
artery disease, is related to ED in a J-shaped manner, with moderate consumption 
conferring the highest protection and higher consumption less benefits. In epidemio-
logical studies, it is difficult to distinguish the ethanol effects from those of associ-
ated confounding factors. Meanwhile, long-term alcohol users, especially in those 
with alcohol liver disease, are highly associated with ED. More research is needed to 
investigate the true effects of alcohol consumption on cardiovascular diseases or ED.
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1.  Introduction
Alcohol beverages (ethyl alcohol or ethanol), tobacco and 
caffeine are the most widely used psychoactive substances 
since time immemorial. People consume alcohol for a wide 
range of reasons in different social and cultural contexts. 
It may be consumed for sociability, cultural participation, 
religious observance or celebratory occasions and may 
serve a symbolic purpose in a round of toasting or as a 
sacrament. People may drink alcohol for pleasure, relaxa-
tion, mood alteration, enhanced creativity, intoxication, 
addiction, forgetting sorrows or for thirst-quenching. 
Alcohol is always taken orally in the forms of beer, wine 
and distilled spirits.
The use of alcohol also carries with it the potential for 
harm, whether in the short term or long term. Alcohol 
consumption is a major factor in much of the injury result-
ing from road crashes, accidents and in social problems. 
The consumption of alcoholic beverages is a common 
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feature of daily living that affects blood pressure, uric 
acid, and thrombogenesis, and also appears to influence 
the risk of cardiovascular disease, both favorably and 
adversely. Excessive ethanol consumption is associated 
with many medical disorders, including liver cirrhosis, 
cardiomyopathy, poor general health and malnutrition.1 
On the other hand, epidemiological studies have shown 
that daily light to moderate consumption of alcohol con-
fers cardioprotective benefits and decreases cardiovascu-
lar disease morbidity and mortality.2,3 The combination of 
protective and harmful influences of alcohol consumption 
results in a U-shaped mortality curve.
Erectile dysfunction (ED) is a highly prevalent medi-
cal disorder with significant impact on quality of life and 
interpersonal relationships. Meanwhile, ED is regarded as 
an early marker of systemic atherosclerosis, a predictor 
for coronary artery disease (CAD) and cardiac events.4 
An epidemiological study has demonstrated that ED 
shares the same risk factors as vascular disease, including 
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smoking, hypertension, diabetes, dyslipidemia, obesity 
and metabolic syndrome.5 The pathophysiology of ED 
involves the production of nitric oxide (NO), smooth mus-
cle relaxation and endothelial dysfunction in the corpus 
cavernosum.6 It is very interesting to understand the 
potential effects of alcohol consumption on the risk of ED.
2. Effect on Behavior
The blood alcohol concentration reaches its peak about 
30–45 minutes after the consumption of one standard 
drink (about 10 g alcohol) (Table 1).7 It generally takes 
about an hour for the body to clear one standard drink, 
although this varies from person to person. Eating when 
drinking alcohol slows the increase in alcohol concen-
tration as food in the stomach reduces the speed of its 
absorption into the bloodstream. The most obvious and 
immediate effects of alcohol, usually within about 5 min-
utes of being swallowed, are on the brain, beginning with 
feelings of relaxation, wellbeing and loss of inhibitions. As 
the intake of alcohol increases, these effects are coun-
terbalanced by less pleasant effects, such as drowsiness, 
loss of balance, nausea and vomiting, as well as other 
harmful effects. The acute behavioral effects of ethanol 
vary between individuals according to many factors such 
as dose, rate of drinking, sex, body weight, blood alcohol 
level and the time since the previous dose.8 Very small 
amounts of ethanol may be excreted unchanged in urine, 
sweat and the breath while most of it is metabolized 
to acetaldehyde by alcohol dehydrogenase in the liver.9 
Ethanol induces diverse types of tolerance. Metabolic 
tolerance occurs and is a function of the upregulation of 
metabolic enzymes, with the result that an increased dose 
or more frequent use of alcohol is required to obtain the 
desired psychopharmacological effects.
Ethanol increases the inhibitory activity mediated 
by gamma-aminobutyric acid-A receptors that involves 
motor incoordination, anxiolysis and sedation in humans.10 
Alcohol also decreases the excitatory activity mediated 
by glutamate receptors, especially the NMDA (N-methyl 
D-aspartate) receptors.11 These two mechanisms together 
Table 1  Number of standard drinks in common containers 
of various alcoholic beverages*
Category Standard drink(s)
Can, low-strength (2.7% alcohol) beer 0.8
Can, mid-strength (3.5% alcohol) beer 1
Can, full-strength (4.9% alcohol) beer 1.4
100 mL wine (9.5–13.5% alcohol) 1
30 mL nip spirits (37–40% alcohol) 1
700 mL bottle spirits (37–40% alcohol) 22
*Adapted from the Australian National Health and Medical 
Research Council.7
contribute to the general sedative effect of alcohol and 
impairment of memory during periods of intoxication.11 
In addition to the effects on central nervous system re-
ceptors, alcohol suppresses the release of gonadotropin 
and antidiuretic hormone from the pituitary that may be 
associated with hypogonadism and hypovolemic shock in 
alcohol abusers. The chronic abuse of alcohol may cause 
testicular atrophy, inhibition of testosterone production 
and impairment of spermatogenesis, apart from its direct 
oxidative toxicity.12
3. Cardioprotective Effects
Both animal and human epidemiological studies have 
demonstrated beneficial effects of alcohol consumption. 
Monkeys on a high cholesterol diet were found to have 
less arterial obstruction in the group given alcohol com-
pared to placebo.13 There is a considerable body of rather 
consistent data that show a protective effect of light to 
moderate drinking of alcohol against CAD in population-
based studies. A cross-sectional investigation involving 
2500 people by angiographic examination exhibited an 
inverse relationship between the extent of coronary 
artery atherosclerosis and alcohol consumption.14 The 
Framingham Cohort Study based on 24 years of follow-
up found that alcohol consumption is significantly asso-
ciated with a decreased risk of coronary heart disease in 
both men and women after taking other cardiovascular 
risk factors into account (Table 2).15 A meta-analysis of 
case-control and cohort studies including 116,702 sub-
jects from 156 qualified articles performed by Conway 
showed a J-shaped relationship between alcohol con-
sumption and CAD risk.16 He reported that the minimum 
relative risk for CAD was 0.80 at 20 g ethanol/day, a sig-
nificant protective effect occurred at up to 72 g ethanol/
day and a significantly increased risk was present at 90 g 
ethanol/day. Based on 52,364 cases from a meta-analysis, 
Maclure suggested that the full preventive effect could be 
achieved by as little as half a drink per day, and that there 
is no further benefit with increasing intake beyond this.17
A balanced view of alcohol drinking and health should 
consider not only harmful and beneficial effects, but also 
the amount of alcohol consumption, beverage choice, 
and drinking patterns. Alcohol, particularly red wine, has 
been found to contain powerful antioxidants that favor ably 
affect many aspects of coagulation and thrombolysis.18 
Klatsky et al.19 collected demographic and history data 
from 128,934 adults and concluded that frequency of 
wine drinking but not of liquor or beer drinking was in-
dependently related to lower mortality risk, especially 
for CAD and respiratory deaths. The relative risks of myo-
cardial infarction were almost identical for consumers 
of beer, wine and spirits in a meta-analysis.17 Frequent 
small amounts (consumed several times per week, per-
haps daily) appear to be more protective than the same 
amount taken at one sitting (binge drinking).20 Coronary 
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artery occlusions have also been found to be more ex-
tensive among binge drinkers than daily drinkers of the 
same amount of alcohol per week.20
However, some studies did not find any significant 
cardioprotective effect from alcohol consumption or all-
cause associations with it. A systematic review21 and some 
other studies22 suggested that the cardioprotective or 
all-cause effect may have been overestimated. The prev-
alence and severity of alcoholic myopathy and cadiomy-
opathy is directly related to the lifetime dose of ethanol 
consumed. The cardioprotective effects of ethanol pertain 
to its influence on CAD, but otherwise alcohol consumption 
damages the heart, especially at intakes > 60–80 g/day.23
The best documented mechanism of cardioprotection 
from moderate consumption of alcohol was attributed 
to the elevation of high-density lipoprotein (HDL) sub-
fractions (HDL2 and HDL3).24 In addition, alcohol consump-
tion was associated with an increase in the prostacycline/
thromboxane ration, decreased platelet aggregability, 
increased release of plasminogen activator, and lower 
fibrinogen.25 Animal study of rats fed with alcohol and 
endothelial NO synthase (eNOS) protein for 8 weeks 
demonstrated that moderate alcohol intake improved 
postischemic myocardial function and increased NO pro-
duction by the vascular endothelium.26 Another animal 
study also supported the protective effect of NO through 
alcohol consumption.27 On the contrary, some animal 
studies found endothelial oxidative injury and downreg-
ulation of the NO generating system that might impair 
erectile function.28,29 Alcohol may also increase energy 
intake and fat storage further by increasing appetite and 
displacing fat and carbohydrate oxidation that are harm-
ful to health.
4. Impact on the Risk of ED
The relationship between alcohol consumption and ED 
is complex. The consumption of alcohol often precedes 
sexual activity and alcohol is commonly believed to be a 
powerful sexual facilitator and aphrodisiac due to its dis-
inhibition properties. Meanwhile, alcohol has long been 
regarded as a risk factor for ED, whether in textbooks, 
review articles or in clinical teaching.
Nevertheless, most population-based epidemiologi-
cal studies have constantly demonstrated that alcohol 
consumption, like its relationship with CAD, is related to 
erectile function in a J-shaped manner, with moderate 
consumption conferring the highest protection and greater 
consumption fewer benefits (Table 3).30–41 Chew et al.30 
conducted a population-based cross-sectional study on 
1770 Australian men and found that compared with never-
drinkers, the age-adjusted odds of ED were lower among 
current, weekend and binge drinkers and higher among 
ex-drinkers. Meta-analysis of population-based cross-
sectional studies found significantly decreased odds of 
ED among alcohol drinkers in 7 of the 11 studies cited.42 
Similar results have been reported in longitudinal studies. 
However, the prospective Massachusetts Male Aging Study 
enrolled 513 men without ED at baseline and the results 
showed that there was no significant difference in the 
incidence of ED among different degrees of alcohol con-
sumption, after adjusting for confounding factors.31 The 
Boston Area Community Health Survey showed signifi-
cantly decreased odds of moderate to severe ED with 
alcohol use of one to three drinks a day.32
Considering that ED and heart disease share similar 
cardiovascular risk factors, and taking into account the 
well-known chronic cytotoxic effects of alcohol on hepatic 
function and immune function, general health might be 
a mediator between the association of high alcohol con-
sumption and ED. This finding of a J-shaped relationship 
might explain why studies have shown harmful effects 
of heavy alcoholism on erectile function.
Chronic and long-term alcohol use directly or indirectly 
affects nearly every organ system in the body. O’Farrell 
et al.43 found that alcoholic men had more than three 
times the prevalence of serious ED of demographically 
Table 2  Coronary heart disease mortality by alcohol consumption in the Framingham Study 24-year follow-up after adjusting 
for age*
 Men Women
Alcohol consumption
 Non-smokers Heavy smokers 
Alcohol consumption
 Non-smokers Heavy smokers
(oz/wk)†   (oz/wk)†
None 16.3 28.3 None 5.5 6.3
1 14.8 16.0 1 5.4 3.7
2–3 14.6 14.4 2–3 1.9 3.0
4–7  7.8 14.0 4–9 6.5 4.6
8–19  5.7 13.1 ≥ 10 5.9 5.0
≥ 20  7.4 12.5
*Data presented as %; †1 ounce of alcohol is equal to 2.0–2.5 standard drinks, with a drink being defined as 12 ounces of beer, 4–5 ounces 
of wine, or 1.25 ounces of 80 proof spirits. (Adapted from Reference 15.)
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Table 3 Summary of population-based studies of alcohol consumption on erectile dysfunction
Authors Sample 
Category of alcohol OR (95% CI) for
 Study design
  consumption having ED
Chew 1580 Australian men Never-drinkers 1 Population-based cross-sectional
et al.30 aged 20–80+ yr < 1 drink/wk 0.78 (0.31–2.00) study; ED assessed by IIEF-5
  1–20 drinks/wk 0.54 (0.24–1.24)
  21–30 drinks/wk 0.56 (0.22–1.42)
  > 30 drinks/wk 0.59 (0.23–1.53)
Feldman 513 American men < 1 drink/d 1 Prospective cohort study from 
et al.31 aged 40–70 yr 1–3 drinks/d 0.95 (0.54–1.67) MMAS; ED assessed by a
  ≥ 4 drinks/d 0.87 (0.41–1.86) single question
Bacon 22,086 American men 0 g/d 1 Prospective cohort study from 
et al.32 aged 40–75 yr 0.1–4.9 g/d 1.0 (0.9–1.1) HPFS; ED assessed by a
  5.0–14.9 g/d 1.0 (0.9–1.1) single question
  15.0–29.9 g/d 1.0 (0.9–1.1)
  ≥ 30 g/d 1.1 (1.0–1.2)
Millett 8367 Australian men Non-drinker 1 Cross-sectional random study; 
et al.33 aged 16–59 yr 1–4 drinks/d 0.36 (0.28–0.45) ED assessed by a
  > 4 drinks/d 0.89 (0.81–1.34) single question
Terai 2084 Japanese men Daily/not daily 1.70 (0.96–2.99) Cross-sectional study of
et al.34 aged 40–60+ yr    noninstitutionalized men;
ED assessed by IIEF-5
Cho 3501 Korean men None or light (< 3/wk) 1 Cross-sectional hospital-based
et al.35 aged 20–60+ yr Moderate (3–4/wk) 0.91 (0.70–1.18) sample; ED assessed by IIEF-5 
  Heavy (> 4/wk) 1.36 (0.95–1.96)
Bai 2203 Chinese men Yes/No 0.69 (0.56–0.84) Cross-sectional population-based
et al.36 aged 20–86 yr   study; ED assessed by IIEF-5
Shaeer 1814 Pakistani, Egyptian Yes/No 0.53 (0.39–0.74) Random hospital-based sample; 
et al.37 or Nigerian men   ED assessed by a single question
 aged 35–70 yr
Nicolosi 2417 Brazilian, Italian,  None 1 Community-based cross-sectional 
et al.38 Japanese or Malay men 1–7 drinks/wk 0.74 (0.53–1.02) study; ED assessed by a 
 aged 40–70 yr ≥ 8 drinks/wk 0.73 (0.53–0.99) single question
Moreira 602 Brazilian men Yes/No 0.54 (0.37–0.87) Cross-sectional population study; 
et al.39 aged 40–70 yr   ED assessed by a single question
Akkus 1982 Turkish men Yes/No 0.55 (0.36–0.85) Stratified random sample; ED
et al.40 aged ≥ 40 yr   assessed by a single question
Mak 799 Belgian men < 20 g/d 1 Aged-stratified random
et al.41 aged 40–70 yr 20–40 g/d 0.56 (0.37–0.84) population study; 
  > 40 g/d 1.29 (0.88–1.88) ED assessed by IIEF
OR = odds ratio; CI = confidence interval; ED = erectile dysfunction; IIEF = International Index of Erectile Function; MMAS = Massachusetts Male 
Aging Study; HPFS = Health Professionals Follow-up Study.
similar nonalcoholic men. Mandell and Miller44 inter-
viewed 44 alcoholic men and found that 59% experienced 
ED during periods of heavy drinking and 84% reported 
some sexual dysfunction related to alcohol abuse. Snyder 
and Karacan45 measured nocturnal penile tumescence 
in a sample of 26 alcoholic men going through detoxifi-
cation, and found that alcoholic men were more likely 
to have fewer, slower and less rigid nocturnal erections 
than a nonalcoholic comparison group. The research from 
Lemere and Smith46 suggested that many alcoholics suf-
fered from ED even after years of sobriety, possibly due 
to the permanent neurological damage caused by long-
term alcohol use. Some long-term male alcoholics may 
experience feminization syndrome associated with ad-
vanced liver cirrhosis and characterized by ED, testicular 
atrophy and gynecomastia.47
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5. Limitations
ED is a mutifactorial disorder, and the association between 
alcohol and ED could be confounded by other factors. In 
epidemiologic studies, it is difficult to distinguish the ef-
fects of ethanol from those of associated socioeconomic 
influences, tobacco, drug abuse, or diet. Poor health habits 
are common in alcohol abusers. Causal inference from 
the cross-sectional design is weak. The alternatives for 
better causal inference are either a cohort study or a 
randomized controlled trial, but in either case, few studies 
have been done. The focus of relevant studies is gen-
erally on health risks, without consideration of alcohol-
attributable social harm. It should be noted that the 
potential cardiovascular or erectile function benefits form 
alcohol consumption can also be gained from other means, 
such as exercise or diet modification.48
In addition to amount of consumption, drinking be-
haviors and the above confounders, there are a number 
of additional factors that influence the effect of alcohol 
consumption. Klatsky et al.19 reported that individuals 
who prefer wine tend to have amore favorable lifestyles, 
better cardiovascular risk profiles, smoke less and are 
better educated. More research needs to be done to as-
sess the association between acute and chronic alcohol 
consumption and the development of ED, particularly 
using large-scale cohorts since randomized controlled 
trials may be unethical.
6. Conclusion
ED and CAD share similar risk factors. Most epidemio-
logical studies have found that alcohol consumption, like 
its relationship with CAD, is related to erectile function 
in a J-shaped manner, with moderate consumption con-
ferring the highest protection and greater consumption 
fewer benefits. The beneficial effects of alcohol are at-
tributed to its antioxidant, vasorelaxant and antithrom-
botic properties, as well as elevation of HDL and increase 
of NO production. Nevertheless, alcoholism is reported to 
be highly associated with cardiomyopathy and ED. More 
studies are needed to assess the effect of alcohol consump-
tion on cardiovascular disease and erectile function.
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